vivitide Revenue and Competitors

Gardner, MA USA

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • vivitide's estimated annual revenue is currently $18.6M per year.(i)
  • vivitide's estimated revenue per employee is $155,000

Employee Data

  • vivitide has 120 Employees.(i)
  • vivitide grew their employee count by 28% last year.

vivitide's People

NameTitleEmail/Phone
1
Account ManagerReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$430.5M4393-1%$292.9M$1B
Add Company

What Is vivitide?

vivitide, a global leader in custom peptides and antibody services for research in the life science and biotech industry,was formed by the merger of New England Peptide (founded 1998) and Peptides International (founded in 1983). With exceptional customer service, our employees take pride in being part of a vibrant life science community. Our focus is on helping researchers around the globe in their drug discovery, pre-clinical and clinical development activities with our combined 50+ years of peptide chemistry knowhow and experience. Headquartered in Gardner, MA, with significant operations in Louisville, KY, vivitide is a leading provider of custom peptide synthesis services, custom antibodies, catalog peptides and biochemicals to academia, pharmaceutical, biotech, and diagnostic companies worldwide. Well known for delivering the highest quality of products and manufacturing capabilities ranging from mg to kg, vivitide has furthermore the unique expertise in complex peptide synthesis, such as RGD peptides. The manufacturing of personalized peptides and throughput production are as important to us as antigen design, antibody purification, and custom peptide-antibody conjugation.

keywords:N/A

N/A

Total Funding

120

Number of Employees

$18.6M

Revenue (est)

28%

Employee Growth %

N/A

Valuation

N/A

Accelerator

vivitide News

2022-03-22 - KKR's Biosynth acquires Vivitide

KKR has closed its acquisition of UK life sciences company Biosynth Carbosynth, as well as Biosynth's acquisition of Vivitide,...

2022-03-22 - KKR-backed Biosynth Carbosynth Acquires vivitide and ...

vivitide is a global provider of custom peptides, antibody services, and catalog products for the life science and biotech industry. Formed by...

2022-03-22 - Two Law Firms Steer as KKR-Backed Biopharma Unit Buys ...

Vivitide is a Gardner, Massachusetts-based maker of custom peptides and antibodies for the biotech industry. McDermott Will & Emery said it...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$15M1253%N/A
#2
$28.3M14325%N/A
#3
$15M1902%N/A
#4
$35M2224%N/A
#5
$375M992N/AN/A